• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study.

作者信息

Lohse Anne, Bossert Marie, Bozgan Ana-Maria, Charpentier Aline, Guillochon Cerise, Bourgoin Charlotte, Balblanc Jean-Charles, Conrozier Thierry

机构信息

Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.

Clinical Research Unit, Nord Franche-Comté Hospital, Belfort, France.

出版信息

Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1273. Epub 2020 Nov 22.

PMID:33253100
Abstract
摘要

相似文献

1
Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study.接受生物性改善病情抗风湿药物治疗的炎症性风湿病患者中新冠病毒病的发生率和严重程度：一项横断面研究
Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1273. Epub 2020 Nov 22.
2
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.COVID-19 在接受靶向生物制剂和合成疾病修饰抗风湿药物治疗的成人和儿科风湿性疾病患者队列中的发病率。
Semin Arthritis Rheum. 2020 Aug;50(4):564-570. doi: 10.1016/j.semarthrit.2020.05.001. Epub 2020 May 16.
3
Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members.接受肿瘤坏死因子抑制剂治疗的幼年特发性关节炎患者接触了新冠病毒感染的家庭成员。
Semin Arthritis Rheum. 2020 Dec;50(6):1214-1215. doi: 10.1016/j.semarthrit.2020.09.012. Epub 2020 Oct 2.
4
Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs.使用生物药物治疗的风湿性疾病儿童感染新冠病毒后无严重并发症
J Rheumatol. 2021 Aug;48(8):1343-1344. doi: 10.3899/jrheum.200483. Epub 2020 Apr 25.
5
[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].[一项关于炎症性风湿疾病患者在新冠疫情期间免疫抑制药物治疗依从性的横断面研究]
Z Rheumatol. 2020 May;79(4):379-384. doi: 10.1007/s00393-020-00800-8.
6
Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini .风湿性疾病患者中新型冠状病毒肺炎（COVID-19）的患病率：需要等待大型合作研究的结果。对Conticini所著《一大群接受生物和靶向合成抗风湿药物治疗的患者中的COVID-19肺炎》的回应
Ann Rheum Dis. 2021 Feb;80(2):e15. doi: 10.1136/annrheumdis-2020-217738. Epub 2020 May 15.
7
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.一大群接受生物和靶向合成抗风湿药物治疗的患者中的新冠肺炎肺炎
Ann Rheum Dis. 2021 Feb;80(2):e14. doi: 10.1136/annrheumdis-2020-217681. Epub 2020 May 15.
8
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland.使用靶向合成或生物改善病情抗风湿药物或甲氨蝶呤治疗的风湿性疾病患者中新冠病毒病的患病率、入院率及缺氧情况：冰岛的一项全国性研究
Ann Rheum Dis. 2021 May;80(5):671-672. doi: 10.1136/annrheumdis-2020-219564. Epub 2021 Jan 5.
9
COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.法国慢性炎症性风湿病患者的 COVID-19：临床特征、风险因素和治疗依从性。
Joint Bone Spine. 2021 Jan;88(1):105095. doi: 10.1016/j.jbspin.2020.105095. Epub 2020 Nov 2.
10
Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops .对舒尔茨 - 库普斯所著的《接受利妥昔单抗治疗的炎症性风湿病患者发生重症 COVID-19 的风险增加》的回应 。
Ann Rheum Dis. 2021 May;80(5):e68. doi: 10.1136/annrheumdis-2020-218148. Epub 2020 Jun 26.